CKD-mineral and bone disorder (CKD-MBD)
CKD-MBD · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Disturbed calcium, phosphate, PTH and vitamin D metabolism in CKD driving secondary hyperparathyroidism, vascular calcification and renal osteodystrophy. Management targets phosphate control, vitamin D repletion and PTH suppression rather than normalising every number.
Red flags
- Painful violaceous skin plaques/necrosis suggesting calciphylaxis
- Severe symptomatic hypercalcaemia
- Pathological fracture or severe bone pain
- Rapidly rising PTH with hypercalcaemia (tertiary hyperparathyroidism)
- Extensive vascular/cardiac valve calcification
Assessment
Differential diagnosis
- Secondary hyperparathyroidism of CKD
- Tertiary (autonomous) hyperparathyroidism
- Adynamic bone disease (over-suppressed PTH)
- Osteomalacia / vitamin D deficiency
- Primary hyperparathyroidism
- Aluminium bone disease (rare)
Investigations
- Corrected calcium, phosphate, ALP
- Intact PTH (trend, not single value)
- 25-OH vitamin D
- eGFR and CKD stage
- Bicarbonate (acidosis worsens bone loss)
- Lateral abdominal X-ray / echo for vascular calcification if considering therapy change
Management
- Stage CKD and establish baseline Ca, PO4, PTH, 25-OH vitamin D and ALP; monitor frequency by stage (G3 6-12 monthly, G4 3-6 monthly, G5/dialysis 1-3 monthly)
- Treat hyperphosphataemia first with dietary phosphate restriction (800-1000 mg/day, limit additives/processed foods) and dietitian referral
- Add oral phosphate binder taken with meals if phosphate persistently elevated; prefer non-calcium binders (sevelamer, lanthanum) where calcium load or vascular calcification is a concern
- Correct 25-OH vitamin D deficiency with colecalciferol before using active analogues
- Avoid routine normalisation of mildly low calcium; treat symptomatic or progressive hypocalcaemia
- For persistently high/rising PTH despite phosphate and vitamin D correction, add active vitamin D (alfacalcidol or calcitriol) at low dose and titrate
- In dialysis patients with refractory secondary hyperparathyroidism add a calcimimetic (cinacalcet or IV etelcalcetide)
- Correct metabolic acidosis to bicarbonate >=22 mmol/L with oral sodium bicarbonate
- Avoid oversuppressing PTH (risk of adynamic bone); keep dialysis PTH roughly 2-9x upper limit of normal
- Refer for parathyroidectomy if severe refractory hyperparathyroidism, symptomatic hypercalcaemia, calciphylaxis or intractable pruritus
- Screen for and manage calciphylaxis urgently if painful skin necrosis appears
- Reassess bone/mineral targets and medication burden at each review
Drugs & doses
Colecalciferol 20,000-50,000 units PO weekly (deficiency), then 800-2000 units PO daily maintenance
Sevelamer carbonate 800-2400 mg PO three times daily with meals
Lanthanum carbonate 500-1000 mg PO three times daily chewed with meals
Calcium acetate 1000 mg PO three times daily with meals (if calcium-based binder appropriate)
Alfacalcidol 250-500 nanograms PO daily, titrated to PTH
Cinacalcet 30 mg PO daily initially, titrate to max 180 mg daily
Sodium bicarbonate 500-1000 mg PO two to three times daily for acidosis
Disposition
Outpatient nephrology/CKD clinic management; dietitian input. Refer to endocrine surgery for parathyroidectomy in refractory disease. Admit urgently for calciphylaxis or severe symptomatic hypercalcaemia.
Complications & pitfalls
- Renal osteodystrophy and fractures
- Vascular and valvular calcification, cardiovascular death
- Calciphylaxis
- Tertiary hyperparathyroidism needing surgery
- Adynamic bone disease from oversuppression
- Soft-tissue calcification and pruritus
Exam pearls
- Control phosphate and vitamin D before chasing PTH down
- Avoid high calcium loads where vascular calcification is a concern
- A single PTH is less useful than the trend
- Oversuppressed PTH (adynamic bone) is as harmful as high PTH
- Phosphate binders only work if taken with food
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.